30 Day Trial

NuVasive Reports 1Q19 Revenue of $274.8MM, +5.5% vs. 1Q18

Share:

NuVasive posts 1Q19 revenue of USD $274.8MM, +5.5% vs.1Q18.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.